JRP
VERA icon

Jasper Ridge Partners’s Vera Therapeutics VERA Stock Holding History

Jasper Ridge Partners’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$436K Hold
10,154
– – 0.01% 117
2026
Q1 		$408K Hold
10,154
– – 0.01% 110
2025
Q4 		$514K Sell
10,154
-5,485
-35% -$195K 0.01% 105
2025
Q3 		$454K Hold
15,639
– – 0.01% 113
2025
Q2 		$368K Hold
15,639
– – 0.01% 113
2025
Q1 		$376K Hold
15,639
– – 0.01% 107
2024
Q4 		$661K Hold
15,639
– – 0.02% 95
2024
Q3 		$691K Hold
15,639
– – 0.02% 96
2024
Q2 		$566K Buy
+15,639
New +$620K 0.02% 99

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jasper Ridge Partners's VERA Position: Q2 2026 in Review

Jasper Ridge Partners held its Vera Therapeutics (VERA) position steady in Q2 2026 at 10,154 shares worth $436K. The position accounts for 0.01% of the portfolio, ranked #117.

Jasper Ridge Partners first reported a position in VERA in Q2 2024 and has held it in 9 quarters since. The position peaked at $691K in Q3 2024. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Jasper Ridge Partners held 10,154 shares of Vera Therapeutics worth $436K as of Q2 2026.
  • Jasper Ridge Partners left its Vera Therapeutics share count unchanged in Q2 2026.
  • Vera Therapeutics made up 0.01% of Jasper Ridge Partners's portfolio in Q2 2026, its #117 holding.
  • Jasper Ridge Partners first reported a position in Vera Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Jasper Ridge Partners's Vera Therapeutics position peaked at $691K in Q3 2024.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Jasper Ridge Partners's 13F filing for Q2 2026, filed 13 Aug 2026.